Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc > So the Marketmakers like the deal?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by go4futureon Nov 18, 2010 11:03am
398 Views
Post# 17724188

RE: So the Marketmakers like the deal?

RE: So the Marketmakers like the deal?Lack of market enthusiasm may have something to do with Paladin's intentions to sell up to 12, 921,312 ISA shares on the TSX  as well as the 12,500,000 to ILJIN on deal closing (of their total 24,921,312 shares).
Notice Form posted on Sedar, Nov 16th....
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities